Dale Broadrick, 10% Owner at BioRestorative Therapies, Inc. (BRTX), bought 320,000 shares at $1.32 ($412K) on 2024-02-09, disclosed to the SEC on 2024-02-12.
Open-market purchase of $412k BRTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.25 | 73,959 | $92K | 22.4% |
| 2 | $1.25 | 73,959 | $92K | 22.4% |
| 3 | $1.32 | 86,041 | $114K | 27.6% |
| 4 | $1.32 | 86,041 | $114K | 27.6% |
| Total | $1.29 avg | 320,000 | $412K | 100% |
| Filing → |
| BRTX | SELL | 2023-12-05 | $470 | — | Filing → |
| BRTX | SELL | 2023-12-01 | $525 | — | Filing → |
| BRTX | BUY | 2023-09-18 | $32K | — | Filing → |